Jounce Therapeutics Inc (JNCE) Return on Investment ROI from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Jounce Therapeutics inc   (NASDAQ: JNCE)


Jounce Therapeutics Inc's ROI from its fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Jounce Therapeutics Inc's ROI in the fourth quarter of 2022?
Jounce Therapeutics Inc recorded a cumulative net loss of $0 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on investment (ROI) of -0.08%.

Within the Healthcare sector 254 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2022 from 0 to 3227.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Investment Change TTM -36.13 % -31.41 % -7.25 % 28.85 % 68.43 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 189 136 166 198 234
Return On Investment (TTM) -0.08 % -0.01 % -0.01 % -0.01 % -0.01 %
JNCE's Overall Ranking # 3227 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -6.11 % -14.66 % -12.66 % -8.74 % 0.83 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 0 0 0 0

JNCE Company Profile >> Back to JNCE Roi Comparisons >> See Annual JNCE Return On Investment



Return On Investment JNCE's Ranking
Within: No.
Industry # 27
Sector # 255
Overall # 3227

Return On Investment Statistics
High Average Low
154.69 %
-3.72 %
-159.96 %
(Sep 30 2019)   (Dec 31 2020)







Financial Statements
Jounce Therapeutics Inc's IV. Quarter Investments $ 189 Millions JNCE's Balance sheet
Jounce Therapeutics Inc's IV. Quarter Income $ 0 Millions Quarterly JNCE's Income Statement
JNCE's Income by Division See JNCE's Income by Division


JNCE Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 189 234 225 191 106
Y / Y Investment Growth -19.17 % 3.95 % 17.46 % 80.32 % -54.64 %
Net Income in Millions 0 0 0 114 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -0.07 % -0.01 % -0.01 % 59.37 % -0.04 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
JNCE's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for JNCE's Competitors
Subscribers only: Roi for Jounce Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for JNCE's Customers

Other Ratios
JNCE's Roa JNCE's Inventory Turnover Ratio JNCE's Growth Rates JNCE's Dividend Statistics
JNCE's Profitability Ratios JNCE's Asset Turnover Ratio JNCE's Dividend Growth
JNCE's Roe JNCE's Valuation Ratios JNCE's Financial Strength Ratios JNCE's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.